UK markets closed
NIKKEI 225
38,179.46 -49.65 (-0.13%) HANG SENG
19,115.06 +151.38 (+0.80%) CRUDE OIL
79.15 +0.89 (+1.14%) GOLD FUTURES
2,342.50 -32.50 (-1.37%) DOW
39,431.51 -81.33 (-0.21%) Bitcoin GBP
50,239.72 +1,378.08 (+2.82%)
ADMA Biologics, Inc. (ADMA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.04B |
| Enterprise value | 2.13B |
| Trailing P/E | N/A |
| Forward P/E | 30.40 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.64 |
| Price/book (mrq) | 15.10 |
| Enterprise value/revenue | 6.68 |
| Enterprise value/EBITDA | -18.63 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.43 |
| 52-week change 3 | 110.26% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 9.02 |
| 52-week low 3 | 3.06 |
| 50-day moving average 3 | 6.37 |
| 200-day moving average 3 | 4.71 |
Share statistics
| Avg vol (3-month) 3 | 2.76M |
| Avg vol (10-day) 3 | 3.27M |
| Shares outstanding 5 | 231.77M |
| Implied shares outstanding 6 | 231.81M |
| Float 8 | 227.2M |
| % held by insiders 1 | 2.84% |
| % held by institutions 1 | 78.00% |
| Shares short (30 Apr 2024) 4 | 8.72M |
| Short ratio (30 Apr 2024) 4 | 4.27 |
| Short % of float (30 Apr 2024) 4 | 3.88% |
| Short % of shares outstanding (30 Apr 2024) 4 | 3.76% |
| Shares short (prior month 28 Mar 2024) 4 | 7.29M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -1.29% |
| Operating margin (ttm) | 26.65% |
Management effectiveness
| Return on assets (ttm) | 8.51% |
| Return on equity (ttm) | -2.43% |
Income statement
| Revenue (ttm) | 283.18M |
| Revenue per share (ttm) | 1.25 |
| Quarterly revenue growth (yoy) | 43.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 55.47M |
| Net income avi to common (ttm) | -3.64M |
| Diluted EPS (ttm) | -0.13 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 45.33M |
| Total cash per share (mrq) | 0.2 |
| Total debt (mrq) | 141.43M |
| Total debt/equity (mrq) | 92.01% |
| Current ratio (mrq) | 5.21 |
| Book value per share (mrq) | 0.66 |
Cash flow statement
| Operating cash flow (ttm) | 21.3M |
| Levered free cash flow (ttm) | 7.84M |
© 2024 Yahoo. All rights reserved.